Global Metabotropic Glutamate Receptor 5 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get access now!

Global Metabotropic Glutamate Receptor 5 Market Trends and Opportunities 2025-31

The global Metabotropic Glutamate Receptor 5 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. United States market for Metabotropic Glutamate Receptor 5 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Metabotropic Glutamate Receptor 5 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Metabotropic Glutamate Receptor 5 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Metabotropic Glutamate Receptor 5 players cover Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Eisai Co Ltd, Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Metabotropic Glutamate Receptor 5 Industry Forecast looks at past sales and reviews total world Metabotropic Glutamate Receptor 5 sales in 2024, providing a comprehensive analysis by region and market sector of projected Metabotropic Glutamate Receptor 5 sales for 2025 through 2031. With Metabotropic Glutamate Receptor 5 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metabotropic Glutamate Receptor 5 industry. This Insight Report provides a comprehensive analysis of the global Metabotropic Glutamate Receptor 5 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metabotropic Glutamate Receptor 5 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Metabotropic Glutamate Receptor 5 market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metabotropic Glutamate Receptor 5 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metabotropic Glutamate Receptor 5. This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 5 market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Alloswitch-1 &nbsp;&nbsp;&nbsp; BMS-952048 &nbsp;&nbsp;&nbsp; BMS-955829 &nbsp;&nbsp;&nbsp; Dipraglurant ER &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Major Depressive Disorder &nbsp;&nbsp;&nbsp; Alcohol Addiction &nbsp;&nbsp;&nbsp; Alzheimers Disease &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Addex Therapeutics Ltd &nbsp;&nbsp;&nbsp; Aevi Genomic Medicine Inc &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company &nbsp;&nbsp;&nbsp; Eisai Co Ltd &nbsp;&nbsp;&nbsp; Eli Lilly and Company &nbsp;&nbsp;&nbsp; Heptares Therapeutics Ltd &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Merz Pharma GmbH & Co KgaA &nbsp;&nbsp;&nbsp; Novartis AG &nbsp;&nbsp;&nbsp; Richter Gedeon Nyrt &nbsp;&nbsp;&nbsp; Sumitomo Dainippon Pharma Co Ltd &nbsp;&nbsp;&nbsp; Toray Industries Inc Key Questions Addressed in this Report What is the 10-year outlook for the global Metabotropic Glutamate Receptor 5 market? What factors are driving Metabotropic Glutamate Receptor 5 market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Metabotropic Glutamate Receptor 5 market opportunities vary by end market size? How does Metabotropic Glutamate Receptor 5 break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Metabotropic Glutamate Receptor 5 Segment by Type &nbsp;2.2.1 Alloswitch-1 &nbsp;2.2.2 BMS-952048 &nbsp;2.2.3 BMS-955829 &nbsp;2.2.4 Dipraglurant ER &nbsp;2.2.5 Others &nbsp;2.3 Metabotropic Glutamate Receptor 5 Sales by Type &nbsp;2.3.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Type (2020-2025) &nbsp;2.4 Metabotropic Glutamate Receptor 5 Segment by Application &nbsp;2.4.1 Major Depressive Disorder &nbsp;2.4.2 Alcohol Addiction &nbsp;2.4.3 Alzheimer's Disease &nbsp;2.4.4 Others &nbsp;2.5 Metabotropic Glutamate Receptor 5 Sales by Application &nbsp;2.5.1 Global Metabotropic Glutamate Receptor 5 Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Metabotropic Glutamate Receptor 5 Breakdown Data by Company &nbsp;3.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Company (2020-2025) &nbsp;3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Company &nbsp;3.4 Key Manufacturers Metabotropic Glutamate Receptor 5 Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 5 Product Location Distribution &nbsp;3.4.2 Players Metabotropic Glutamate Receptor 5 Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Metabotropic Glutamate Receptor 5 by Geographic Region &nbsp;4.1 World Historic Metabotropic Glutamate Receptor 5 Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Metabotropic Glutamate Receptor 5 Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Metabotropic Glutamate Receptor 5 Sales Growth &nbsp;4.4 APAC Metabotropic Glutamate Receptor 5 Sales Growth &nbsp;4.5 Europe Metabotropic Glutamate Receptor 5 Sales Growth &nbsp;4.6 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Growth 5 Americas &nbsp;5.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country &nbsp;5.1.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country (2020-2025) &nbsp;5.1.2 Americas Metabotropic Glutamate Receptor 5 Revenue by Country (2020-2025) &nbsp;5.2 Americas Metabotropic Glutamate Receptor 5 Sales by Type (2020-2025) &nbsp;5.3 Americas Metabotropic Glutamate Receptor 5 Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region &nbsp;6.1.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region (2020-2025) &nbsp;6.1.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2020-2025) &nbsp;6.2 APAC Metabotropic Glutamate Receptor 5 Sales by Type (2020-2025) &nbsp;6.3 APAC Metabotropic Glutamate Receptor 5 Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Metabotropic Glutamate Receptor 5 by Country &nbsp;7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2020-2025) &nbsp;7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2020-2025) &nbsp;7.2 Europe Metabotropic Glutamate Receptor 5 Sales by Type (2020-2025) &nbsp;7.3 Europe Metabotropic Glutamate Receptor 5 Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Metabotropic Glutamate Receptor 5 by Country &nbsp;8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 5 &nbsp;10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5 &nbsp;10.4 Industry Chain Structure of Metabotropic Glutamate Receptor 5 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Metabotropic Glutamate Receptor 5 Distributors &nbsp;11.3 Metabotropic Glutamate Receptor 5 Customer 12 World Forecast Review for Metabotropic Glutamate Receptor 5 by Geographic Region &nbsp;12.1 Global Metabotropic Glutamate Receptor 5 Market Size Forecast by Region &nbsp;12.1.1 Global Metabotropic Glutamate Receptor 5 Forecast by Region (2026-2031) &nbsp;12.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Metabotropic Glutamate Receptor 5 Forecast by Type (2026-2031) &nbsp;12.7 Global Metabotropic Glutamate Receptor 5 Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Addex Therapeutics Ltd &nbsp;13.1.1 Addex Therapeutics Ltd Company Information &nbsp;13.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Addex Therapeutics Ltd Main Business Overview &nbsp;13.1.5 Addex Therapeutics Ltd Latest Developments &nbsp;13.2 Aevi Genomic Medicine Inc &nbsp;13.2.1 Aevi Genomic Medicine Inc Company Information &nbsp;13.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Aevi Genomic Medicine Inc Main Business Overview &nbsp;13.2.5 Aevi Genomic Medicine Inc Latest Developments &nbsp;13.3 Bristol-Myers Squibb Company &nbsp;13.3.1 Bristol-Myers Squibb Company Company Information &nbsp;13.3.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Bristol-Myers Squibb Company Main Business Overview &nbsp;13.3.5 Bristol-Myers Squibb Company Latest Developments &nbsp;13.4 Eisai Co Ltd &nbsp;13.4.1 Eisai Co Ltd Company Information &nbsp;13.4.2 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Eisai Co Ltd Main Business Overview &nbsp;13.4.5 Eisai Co Ltd Latest Developments &nbsp;13.5 Eli Lilly and Company &nbsp;13.5.1 Eli Lilly and Company Company Information &nbsp;13.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Eli Lilly and Company Main Business Overview &nbsp;13.5.5 Eli Lilly and Company Latest Developments &nbsp;13.6 Heptares Therapeutics Ltd &nbsp;13.6.1 Heptares Therapeutics Ltd Company Information &nbsp;13.6.2 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Heptares Therapeutics Ltd Main Business Overview &nbsp;13.6.5 Heptares Therapeutics Ltd Latest Developments &nbsp;13.7 Johnson & Johnson &nbsp;13.7.1 Johnson & Johnson Company Information &nbsp;13.7.2 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Johnson & Johnson Main Business Overview &nbsp;13.7.5 Johnson & Johnson Latest Developments &nbsp;13.8 Merz Pharma GmbH & Co KgaA &nbsp;13.8.1 Merz Pharma GmbH & Co KgaA Company Information &nbsp;13.8.2 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Merz Pharma GmbH & Co KgaA Main Business Overview &nbsp;13.8.5 Merz Pharma GmbH & Co KgaA Latest Developments &nbsp;13.9 Novartis AG &nbsp;13.9.1 Novartis AG Company Information &nbsp;13.9.2 Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Novartis AG Main Business Overview &nbsp;13.9.5 Novartis AG Latest Developments &nbsp;13.10 Richter Gedeon Nyrt &nbsp;13.10.1 Richter Gedeon Nyrt Company Information &nbsp;13.10.2 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Richter Gedeon Nyrt Main Business Overview &nbsp;13.10.5 Richter Gedeon Nyrt Latest Developments &nbsp;13.11 Sumitomo Dainippon Pharma Co Ltd &nbsp;13.11.1 Sumitomo Dainippon Pharma Co Ltd Company Information &nbsp;13.11.2 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Sumitomo Dainippon Pharma Co Ltd Main Business Overview &nbsp;13.11.5 Sumitomo Dainippon Pharma Co Ltd Latest Developments &nbsp;13.12 Toray Industries Inc &nbsp;13.12.1 Toray Industries Inc Company Information &nbsp;13.12.2 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolios and Specifications &nbsp;13.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Toray Industries Inc Main Business Overview &nbsp;13.12.5 Toray Industries Inc Latest Developments 14 Research Findings and Conclusion

Report	Global Metabotropic Glutamate Receptor 5 Market Growth 2025-2031
Selected License	Single ID:LPI21118

Buyer Information

Order Summary